Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Clarke Pharmaceutical Manufacturing, Inc.
WARNING LETTER
•Clarke Pharmaceutical Manufacturing, Inc.•February 9, 2021

Clarke Pharmaceutical Manufacturing, Inc. – FDA Warning Letter, Feb 9, 2021

Record Details

The FDA issued a Warning Letter to Dr. Lewis Clarke M.D. and M. Christopher Clarke of Clarke Pharmaceuticals on February 2, 2021, following a review of their website (www.clarkepharmaceuticals.com) and YouTube channel in December 2020 and January 2021. The FDA determined that five products—"OsteoBLAST®," "Cell Block #19," "High Potency Vitamin D3," "Neupanex®," and "Natural Progesterone Skin Cream"—are unapproved new drugs and misbranded.

The products are deemed drugs under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act) due to claims on their website and YouTube videos indicating their intent for disease treatment, prevention, or to affect body structure/function. Specifically, "Cell Block #19" is cited for COVID-19 related claims.

These products are considered "new drugs" under section 201(p) of the Act because they are not generally recognized as safe and effective for their claimed uses. Marketing them without prior FDA approval violates sections 301(d) and 505(a) of the Act. Furthermore, they are misbranded under section 502(f)(1) of the Act because they lack adequate directions for use by a layperson, as their intended uses require supervision

Company
Clarke Pharmaceutical Manufacturing, Inc.
Inspection date
February 9, 2021
Product type
Food
Office
Division of Human and Animal Food Operations - West III
People
  • Edmundo Garcia (Program Director)
  • Dana M. Lewis
View Company Profile

ID · c64f60db-b272-4464-b2fd-f2111a00e675

Violation Codes8
21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(p)21 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 CFR 201.521 U.S.C. 353(b)(1)(A)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Clarke Pharmaceutical Manufacturing, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.